Akili & Shionogi partnership to bring new digital therapeutics to Asia
Category: #health  By Pankaj Singh  Date: 2019-03-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

Akili & Shionogi partnership to bring new digital therapeutics to Asia
  • The new strategic partnership would see the two enterprises collaborate on the development & commercialization of digital therapeutics in crucial Asian markets.
     
  • Potential & upfront milestone payments to Akili for the Taiwan & Japan commercialization are being valued at $125 million.

Akili Interactive (Akili), an American digital medicine company, has reportedly signed a strategic partnership agreement with research-driven Japanese pharmaceutical company, Shionogi & Co., Ltd. (Shionogi) to develop & commercialize digital therapeutics across key markets in Asia.

The collaboration is reportedly to enable the commercialization of Akili’s digital medicines dubbed as AKL-T01 & the AKL-T02, in Taiwan as well as Japan.

According to a press release by Akili Interactive, the AKL-T01 is presently being reviewed by the United States Food & Drug Administration (U.S. FDA), which is determining its credibility as a potential digital therapy for children suffering from attention-deficit/hyperactivity disorder (ADHD). Meanwhile, the AKL-T02 is in the late stages of development and could be used as a potential therapy for cognitive dysfunction & related symptoms for children suffering from Autism Spectrum Disorder (ASD). Both digital treatments are delivered to the patients through immersive action videogames.

The partnership reportedly leverages both enterprise’s unique capabilities to develop a new commercial model & deploy a new class of therapy to the intended patients. Under the terms of the partnership agreement, Shionogi would be responsible for both medicine’s regulatory filings. Moreover, Shionogi would also possess the exclusive rights for the clinical development, marketing & sales of both digital therapeutics across Taiwan & Japan.

Shionogi would reportedly be making an upfront payment totaling $20 million to Akili as part of the deal. Additionally, Akili would also be eligible for substantial commercial & development milestone payments to the tune of $105 million along with significant royalties on both product’s sales in Taiwan & Japan.

According to reports, Akili would be retaining the exclusive global rights for the development & commercialization of both digital therapies across all territories outside of Taiwan & Japan.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Bettervest invests in Oakridge Rooftops to support solar projects
Bettervest invests in Oakridge Rooftops to support solar projects
By Pankaj Singh

Oakridge Rooftops Pvt. Ltd., a solar energy company based in India, has reportedly secured funding from Germany-based crowdfunding platform, Bettervest Gmbh. The solar firm has raised the funding for urban solar projects in New Delhi. Oakridge CEO, ...

Databricks buys 8080 Labs to boost its low code/no code offerings
Databricks buys 8080 Labs to boost its low code/no code offerings
By Pankaj Singh

California-based enterprise software company- Databricks has acquired German software startup 8080 Labs that developed bamboolib- a leading GUI for the Python-based Pandas data analysis and manipulation system. The purchase of 8080 Labs makes the fi...

Google rolls out GNI Advertising Lab for news publishers in India
Google rolls out GNI Advertising Lab for news publishers in India
By Pankaj Singh

American tech giant, Google LLC has recently announced the launch of Google News Initiative (GNI) Advertising Lab program for supporting small and medium-sized news publishers that generate original and accurate news for regional and local communitie...